Fractures, Hip
8
2
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
CoreHip - Post Market Clinical Follow-Up Study
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
Influence of Standardized Perioperative Anesthetic, Analgesic Care on Outcome of Patients Undergoing Hip Fracture Surgeries
Preoperative Use of Peripheral Nerve Blocks in Elderly Patients With Hip Fractures
The PREVENT Trial: a Pragmatic Cluster Randomized Controlled Trial of a Multifaceted Fracture Prevention Model for Long-term Care
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
Mitigation of Major Hip Injury Due to Fall With a Smart Belt